Get the Stockscreener App
2.88
3.97%
0.11
Artiva Biotherapeutics Inc stock is traded at $2.88, with a volume of 50,085.
It is up +3.97% in the last 24 hours and up +11.63% over the past month.
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
See More
Previous Close:
$2.77
Open:
$2.78
24h Volume:
50,085
Relative Volume:
0.25
Market Cap:
$70.35M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+4.73%
1M Performance:
+11.63%
6M Performance:
-23.61%
1Y Performance:
-71.11%
1-Day Range:
$2.78
$2.9753
1-Week Range:
$2.6424
$3.2388
52-Week Range:
$1.47
$17.31
Artiva Biotherapeutics Inc Stock (ARTV) Company Profile
Name
Artiva Biotherapeutics Inc
Sector
Industry
Phone
(858) 267-4467
Address
5505 MOREHOUSE DRIVE, SAN DIEGO
Compare ARTV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARTV
Artiva Biotherapeutics Inc
|
2.88 | 75.53M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Artiva Biotherapeutics Inc Stock (ARTV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-11-25 | Resumed | H.C. Wainwright | Buy |
| Dec-30-24 | Initiated | H.C. Wainwright | Buy |
| Aug-13-24 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-13-24 | Initiated | Jefferies | Buy |
| Aug-13-24 | Initiated | Needham | Buy |
| Aug-13-24 | Initiated | TD Cowen | Buy |
| Aug-13-24 | Initiated | Wedbush | Outperform |
View All
Artiva Biotherapeutics Inc Stock (ARTV) Latest News
Artiva Biotherapeutics Inc. recovery potential after sell off2025 Technical Overview & Daily Stock Trend Watchlist - Newser
Will Breakout in Artiva Biotherapeutics Inc. Sustain Through Next Week2025 Technical Patterns & Community Verified Trade Alerts - newsyoung.net
What’s the recovery path for long term holders of Artiva Biotherapeutics Inc.Weekly Trade Analysis & Risk Controlled Swing Alerts - Newser
Is This the Dip to Buy in Artiva Biotherapeutics Inc.Weekly Stock Analysis & Smart Swing Trading Alerts - thegnnews.com
Tools to assess Artiva Biotherapeutics Inc.’s risk profile2025 Trading Recap & Scalable Portfolio Growth Methods - Newser
Artiva Biotherapeutics Inc. stock trend outlook and recovery pathQuarterly Growth Report & Free Reliable Trade Execution Plans - Newser
Is Artiva Biotherapeutics Inc. still worth holding after the dip2025 Major Catalysts & Smart Allocation Stock Tips - Newser
How to use Fibonacci retracement on Artiva Biotherapeutics Inc.July 2025 Setups & High Conviction Investment Ideas - Newser
Using data filters to optimize entry into Artiva Biotherapeutics Inc.Portfolio Risk Report & Weekly Chart Analysis and Guides - Newser
Real time social sentiment graph for Artiva Biotherapeutics Inc.Quarterly Trade Summary & Weekly Watchlist for Consistent Profits - Newser
Statistical indicators supporting Artiva Biotherapeutics Inc.’s strengthJuly 2025 Pullbacks & Weekly High Potential Stock Alerts - Newser
How to interpret RSI for Artiva Biotherapeutics Inc. stock2025 Volatility Report & Long-Term Growth Stock Strategies - Newser
Is a relief rally coming for Artiva Biotherapeutics Inc. holdersJuly 2025 Intraday Action & Daily Chart Pattern Signals - Newser
Artiva Biotherapeutics Inc.’s volatility index tracking explainedJuly 2025 PostEarnings & Reliable Momentum Entry Alerts - Newser
How sentiment analysis helps forecast Artiva Biotherapeutics Inc.2025 Major Catalysts & Free Growth Oriented Trading Recommendations - Newser
Is Artiva Biotherapeutics Inc. stock bottoming outJuly 2025 Earnings & Fast Entry and Exit Trade Plans - Newser
Published on: 2025-08-19 14:55:14 - Newser
Market reaction to Artiva Biotherapeutics Inc.’s recent news2025 Market Sentiment & Breakout Confirmation Alerts - Newser
Will Artiva Biotherapeutics Inc. benefit from macro trendsShare Buyback & Precise Trade Entry Recommendations - Newser
Artiva Biotherapeutics Inc. stock trendline breakdownWeekly Investment Summary & Accurate Buy Signal Alerts - Newser
Aslan Fred, Artiva Biotherapeutics president, sells $69,579 in shares By Investing.com - Investing.com South Africa
How institutional ownership impacts Artiva Biotherapeutics Inc. stockTrade Analysis Report & Long-Term Safe Return Strategies - Newser
Leading vs lagging indicators on Artiva Biotherapeutics Inc. performance2025 Geopolitical Influence & Long Hold Capital Preservation Plans - Newser
Aslan Fred, Artiva Biotherapeutics president, sells $69,579 in shares - Investing.com
Artiva Biotherapeutics CEO Aslan Fred sells 25500 shares at $2.73/share on 2025-08-15. - AInvest
Strategies to average down on Artiva Biotherapeutics Inc.July 2025 Outlook & Verified Entry Point Signals - Newser
Is Artiva Biotherapeutics Inc. stock overhyped or has real potentialJuly 2025 Sentiment & Community Trade Idea Sharing - Newser
Smart tools for monitoring Artiva Biotherapeutics Inc.’s price actionWeekly Earnings Recap & Safe Entry Momentum Tips - Newser
What to do if you’re stuck in Artiva Biotherapeutics Inc.July 2025 Institutional & Stepwise Swing Trade Plans - Newser
What’s the beta of Artiva Biotherapeutics Inc. stockJuly 2025 Macro Moves & AI Enhanced Trade Execution Alerts - classian.co.kr
Pattern recognition hints at Artiva Biotherapeutics Inc. upsideForecast Cut & Free Weekly Chart Analysis and Trade Guides - Newser
Is Artiva Biotherapeutics Inc. stock entering bullish territoryInflation Watch & Technical Pattern Alert System - Newser
Artiva Biotherapeutics Inc Stock (ARTV) Financials Data
There is no financial data for Artiva Biotherapeutics Inc (ARTV). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):